RETRACTED ARTICLE: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2

RT @JournalofExper1: New study! ✅ 𝐋𝐍𝐂𝐀𝐑𝐎𝐃 enhances #𝐡𝐞𝐩𝐚𝐭𝐨𝐜𝐞𝐥𝐥𝐮𝐥𝐚𝐫𝐜𝐚𝐫𝐜𝐢𝐧𝐨𝐦𝐚 𝐦𝐚𝐥𝐢𝐠𝐧𝐚𝐧𝐜𝐲 by activating #𝐠𝐥𝐲𝐜𝐨𝐥𝐲𝐬𝐢𝐬 through induction of 𝐩𝐲𝐫𝐮…

RT @JournalofExper1: New study! ✅ 𝐋𝐍𝐂𝐀𝐑𝐎𝐃 enhances #𝐡𝐞𝐩𝐚𝐭𝐨𝐜𝐞𝐥𝐥𝐮𝐥𝐚𝐫𝐜𝐚𝐫𝐜𝐢𝐧𝐨𝐦𝐚 𝐦𝐚𝐥𝐢𝐠𝐧𝐚𝐧𝐜𝐲 by activating #𝐠𝐥𝐲𝐜𝐨𝐥𝐲𝐬𝐢𝐬 through induction of 𝐩𝐲𝐫𝐮…

New study! ✅ 𝐋𝐍𝐂𝐀𝐑𝐎𝐃 enhances #𝐡𝐞𝐩𝐚𝐭𝐨𝐜𝐞𝐥𝐥𝐮𝐥𝐚𝐫𝐜𝐚𝐫𝐜𝐢𝐧𝐨𝐦𝐚 𝐦𝐚𝐥𝐢𝐠𝐧𝐚𝐧𝐜𝐲 by activating #𝐠𝐥𝐲𝐜𝐨𝐥𝐲𝐬𝐢𝐬 through induction of 𝐩𝐲𝐫𝐮𝐯𝐚𝐭𝐞 𝐤𝐢𝐧𝐚𝐬𝐞 𝐢𝐬𝐨𝐟𝐨𝐫𝐦 𝐏𝐊𝐌𝟐 For free ⏬ https://t.co/6KTLuiDC9i @IREISGufficiale https://t.co/NrmoobO6KH

New in @BioMedCentral: Researchers found that LNCAROD was significantly upregulated and predicted a poorer prognosis in #HepatocellularCarcinoma patients, providing a promising diagnostic marker and therapeutic target. 🎯 📖 https://t.co/B19n9B64HU https://